GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research
H tr khng vim, gim kch ng, thi c da v tng cng min dch cho da
Orlistat is generally the least favored option due to its side effect profile, and its benefit is reduced if an individual is already following a low-fat diet, although gastrointestinal side effects may persist
After discontinuation, close monitoring is essential: weight should be checked every 4-8 weeks initially, and for diabetes patients, self-monitoring of blood glucose or continuous glucose monitoring should continue as indicated, with A1C assessment within approximately 3 months of stopping to detect metabolic deterioration early and implement alternative management strategies
Its one reason why here at InsideTracker, we developed the InnerAge testweve long been advocates of the idea that you can improve your lifespan with simple changes